Genetics of epilepsy after newborn seizures
NSR-GENE (Neonatal Seizure Registry, GEnetics of post-Neonatal Epilepsy)
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11300168
This project looks for genetic differences in children who had seizures as newborns to help predict which ones may develop epilepsy.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11300168 on ClinicalTrials.gov |
What this research studies
If your child had seizures as a newborn, researchers will invite families from a nine-center Neonatal Seizure Registry to join non-invasive genetic testing. They will combine genetic results with clinical information already collected, like EEG and MRI findings from the newborn period. The team will use those combined data to build prediction models and study biological pathways that might explain why some children go on to develop epilepsy. Participation mainly involves consent for genetic testing and use of existing clinical data rather than new invasive procedures.
Who could benefit from this research
Good fit: Children who had acute symptomatic seizures as newborns (and their parents for genetic sampling) are the primary candidates for participation.
Not a fit: People without a history of neonatal seizures or those whose seizures had a clearly identified and fully explanatory cause unrelated to genetic factors are unlikely to benefit directly.
Why it matters
Potential benefit: If successful, this could help identify newborns at higher risk for epilepsy so they can get closer monitoring or earlier interventions.
How similar studies have performed: Previous work has linked some gene variants to epilepsy, but applying genetic risk models specifically to children after neonatal acute symptomatic seizures is a newer approach.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GLASS, HANNAH CRANLEY — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: GLASS, HANNAH CRANLEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired brain injury